This study will be a formal assessment of the impact of hepatic function impairment on the pharmacokinetics of nilotinib
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
27
Unnamed facility
Richmond, Virginia, United States
Pharmacokinetics of nilotinib
impact on hepatic function assessed by laboratory values and an electrocardiogram
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.